Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Infect Dis. 2010 Mar 1;50(5):e30-3. doi: 10.1086/650488.

Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation.

Author information

1
Department of Nephrology, Dialysis and Organ Transplantation, Centre Hospitalier Universitaire, Toulouse, France. kamar.n@chu-toulouse.fr

Abstract

This study assessed the effect of a 3-month course of pegylated interferon-alpha-2a (Peg-IFN-alpha-2a) in 3 liver transplant patients with chronic active hepatitis E. A virological response was sustained for 6 and 5 months in 2 patients after Peg-IFN-alpha-2a therapy was completed. A relapse was observed in the third patient.

PMID:
20113176
DOI:
10.1086/650488
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center